These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 18211128)

  • 1. A 1-year pilot study of vagus nerve stimulation in treatment-resistant rapid-cycling bipolar disorder.
    Marangell LB; Suppes T; Zboyan HA; Prashad SJ; Fischer G; Snow D; Sureddi S; Allen JC
    J Clin Psychiatry; 2008 Feb; 69(2):183-9. PubMed ID: 18211128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome.
    Sackeim HA; Rush AJ; George MS; Marangell LB; Husain MM; Nahas Z; Johnson CR; Seidman S; Giller C; Haines S; Simpson RK; Goodman RR
    Neuropsychopharmacology; 2001 Nov; 25(5):713-28. PubMed ID: 11682255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lamotrigine adjunctive therapy to lithium and divalproex in depressed patients with rapid cycling bipolar disorder and a recent substance use disorder: a 12-week, double-blind, placebo-controlled pilot study.
    Wang Z; Gao K; Kemp DE; Chan PK; Serrano MB; Conroy C; Fang Y; Ganocy SJ; Findling RL; Calabrese JR
    Psychopharmacol Bull; 2010; 43(4):5-21. PubMed ID: 21240149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venlafaxine versus lithium monotherapy of rapid and non-rapid cycling patients with bipolar II major depressive episode: a randomized, parallel group, open-label trial.
    Amsterdam JD; Wang CH; Shwarz M; Shults J
    J Affect Disord; 2009 Jan; 112(1-3):219-30. PubMed ID: 18486235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group.
    Calabrese JR; Bowden CL; Sachs GS; Ascher JA; Monaghan E; Rudd GD
    J Clin Psychiatry; 1999 Feb; 60(2):79-88. PubMed ID: 10084633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating response to mood stabilizers in patients with mixed depression: A study of agreement between three different mania rating scales and a depression rating scale.
    Shansis FM; Reche M; Capp E
    J Affect Disord; 2016 Jun; 197():1-7. PubMed ID: 26950019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pilot study of vagus nerve stimulation (VNS) for treatment-resistant anxiety disorders.
    George MS; Ward HE; Ninan PT; Pollack M; Nahas Z; Anderson B; Kose S; Howland RH; Goodman WK; Ballenger JC
    Brain Stimul; 2008 Apr; 1(2):112-21. PubMed ID: 20633378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bipolar I and II disorder residual symptoms: oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial.
    Juruena MF; Ottoni GL; Machado-Vieira R; Carneiro RM; Weingarthner N; Marquardt AR; Fleig SS; Broilo L; Busnello EA
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):94-9. PubMed ID: 19007842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is intravenous valproate more efficacious than oral valproate for inpatients with bipolar I disorder with a manic or depressive episode and concomitant symptoms of opposite polarity?
    Cuomo A; Barillà G; Cattolico M; Carmellini P; Spiti A; Pozza A; Fagiolini A
    Bipolar Disord; 2024 May; 26(3):277-283. PubMed ID: 37957926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vagus nerve stimulation for depression: efficacy and safety in a European study.
    Schlaepfer TE; Frick C; Zobel A; Maier W; Heuser I; Bajbouj M; O'Keane V; Corcoran C; Adolfsson R; Trimble M; Rau H; Hoff HJ; Padberg F; Müller-Siecheneder F; Audenaert K; Van den Abbeele D; Stanga Z; Hasdemir M
    Psychol Med; 2008 May; 38(5):651-61. PubMed ID: 18177525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial.
    Rush AJ; Marangell LB; Sackeim HA; George MS; Brannan SK; Davis SM; Howland R; Kling MA; Rittberg BR; Burke WJ; Rapaport MH; Zajecka J; Nierenberg AA; Husain MM; Ginsberg D; Cooke RG
    Biol Psychiatry; 2005 Sep; 58(5):347-54. PubMed ID: 16139580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes.
    Nahas Z; Marangell LB; Husain MM; Rush AJ; Sackeim HA; Lisanby SH; Martinez JM; George MS
    J Clin Psychiatry; 2005 Sep; 66(9):1097-104. PubMed ID: 16187765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid-cycling bipolar I disorder: course and treatment outcome of a large sample across Europe.
    Cruz N; Vieta E; Comes M; Haro JM; Reed C; Bertsch J;
    J Psychiatr Res; 2008 Oct; 42(13):1068-75. PubMed ID: 18262204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 5-Year Observational Study of Patients With Treatment-Resistant Depression Treated With Vagus Nerve Stimulation or Treatment as Usual: Comparison of Response, Remission, and Suicidality.
    Aaronson ST; Sears P; Ruvuna F; Bunker M; Conway CR; Dougherty DD; Reimherr FW; Schwartz TL; Zajecka JM
    Am J Psychiatry; 2017 Jul; 174(7):640-648. PubMed ID: 28359201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study.
    Rush AJ; Sackeim HA; Marangell LB; George MS; Brannan SK; Davis SM; Lavori P; Howland R; Kling MA; Rittberg B; Carpenter L; Ninan P; Moreno F; Schwartz T; Conway C; Burke M; Barry JJ
    Biol Psychiatry; 2005 Sep; 58(5):355-63. PubMed ID: 16139581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.
    Houston JP; Tohen M; Degenhardt EK; Jamal HH; Liu LL; Ketter TA
    J Clin Psychiatry; 2009 Nov; 70(11):1540-7. PubMed ID: 19778495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness and safety of vagus nerve stimulation for severe treatment-resistant major depression in clinical practice after FDA approval: outcomes at 1 year.
    Cristancho P; Cristancho MA; Baltuch GH; Thase ME; O'Reardon JP
    J Clin Psychiatry; 2011 Oct; 72(10):1376-82. PubMed ID: 21295002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risperidone safety and efficacy in the treatment of bipolar and schizoaffective disorders: results from a 6-month, multicenter, open study.
    Vieta E; Goikolea JM; Corbella B; Benabarre A; Reinares M; Martínez G; Fernández A; Colom F; Martínez-Arán A; Torrent C;
    J Clin Psychiatry; 2001 Oct; 62(10):818-25. PubMed ID: 11816872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of risperidone in the treatment of schizoaffective disorder: initial results from a large, multicenter surveillance study. Group for the Study of Risperidone in Affective Disorders (GSRAD).
    Vieta E; Herraiz M; Fernández A; Gastó C; Benabarre A; Colom F; Martínez-Arán A; Reinares M
    J Clin Psychiatry; 2001 Aug; 62(8):623-30. PubMed ID: 11561935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Open-label aripiprazole in the treatment of acute bipolar depression: a prospective pilot trial.
    McElroy SL; Suppes T; Frye MA; Altshuler LL; Stanford K; Martens B; Leverich GS; Post RM; Keck PE
    J Affect Disord; 2007 Aug; 101(1-3):275-81. PubMed ID: 17229469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.